A61K 2039/852
Pancreas
Official title: {Pancreas}
A61K2039/852 (Pancreas) appears on 55 US grants and 138 published applications in this corpus.
Search patents in A61K- Granted patents
- 55
- Published applications
- 138
- Assignees
- 79
- Inventors
- 276
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 2 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 0 | 2 |
| 2019 | 2 | 7 |
| 2020 | 2 | 17 |
| 2021 | 5 | 20 |
| 2022 | 9 | 26 |
| 2023 | 7 | 13 |
| 2024 | 11 | 23 |
| 2025 | 10 | 16 |
| 2026 | 6 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Intracellular delivery of biomolecules to modify immune response8 Sep 2026US 12,728,163 B2Stemcell Technologies Canada Inc.
- Compositions and methods for cancer therapy25 Aug 2026US 12,714,723 B2AIM ImmunoTech Inc.
- Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent9 Jun 2026US 12,648,970 B2The Curators of the University of Missouri
- Treatment of Krabbe disease with umbilical cord blood transplantion (UCBT) and increased galactocerebrosidase (GALC) expression14 Apr 2026US 12,599,636 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Methods and compositions for treatment of pancreatic cancer7 Apr 2026US 12,594,324 B2
- Peptide-based vaccines and methods for treatment24 Sep 2026US 2026/0284163 A1The Johns Hopkins University
- Treatment of krabbe disease with umbilical cord blood transplantation (ucbt) and increased galactocerebrosidase (galc) expression6 Aug 2026US 2026/0224639 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- haNK Cetuximab Combinations And Methods28 May 2026US 2026/0144868 A1NantCell, Inc.
- Systems and methods for targeting cancer cells19 Mar 2026US 2026/0078200 A1The Regents of the University of California
- Pharmaceutical Composition, Preparation Method and Use Thereof19 Feb 2026US 2026/0048111 A1PuGong Biotech (Hangzhou) Co., Ltd.
Most cited
By later US patents
- DNA vaccine for use in pancreatic cancer patients13US 9,415,098 B2Vaximm AG · 2016
- Method of compact peptide vaccines using residue optimization10US 11,161,892 B1Think Therapeutics, Inc. · 2021
- Compositions for optimized RAS peptide vaccines9US 11,058,751 B1Think Therapeutics, Inc. · 2021
- DNA vaccine for use in pancreatic cancer patients8US 10,293,037 B2Vaximm AG · 2019
- Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers7US 10,400,011 B2Immatics Biotechnologies GmbH · 2019